HERO Study Validates Outstanding Results for Optimed sinus SuperFlex 635 Stent

A new multicentre HERO Registry study has confirmed that the Optimed sinus SuperFlex 635 stent delivers excellent clinical outcomes for patients with complex femoropopliteal lesions.

Key highlights from the HERO Registry include:

  • 78.5% primary patency at 12 months: The majority of patients experienced continued vessel openness one year after their procedure.
  • Exceptionally low stent fracture rate (0.9%): The stent’s robust design minimises complications, ensuring long-term durability.
  • Over 88% clinical improvement (Rutherford class 0–1): Most patients saw significant symptom relief and improved quality of life.

The sinus-SuperFlex-635 stent stands out due to its innovative hybrid design, featuring secure closed-cell ends for stability, and a flexible open-cell mid-section for adaptability. This combination makes it a safe and reliable choice for treating challenging femoropopliteal artery lesions.

Discover more about the HERO study and the sinus-SuperFlex-635 stent’s impact on patient care

Contact us for more information

More articles…

+

The Prestige and Prestige Plus Coil System

The Prestige and Prestige Plus Coil System is an innovative device to endovascularly obstruct or occlude blood flow in vascular abnormalities of...Read More
+

Solero – Microwave Tissue Ablation System

The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue. The Solero MTA System is...Read More
+

Comprehensive Solutions for Biliary Stenting: The Taewoong Niti-S™ Portfolio

Taewoong’s Niti-S™ range offers one of the most comprehensive portfolios in the field of biliary stenting, addressing both benign and malignant biliary...Read More
+

University Hospitals Plymouth NHS Trust has uses Auryon Laser Atherectomy System

Congratulations to the Interventional Radiology team at University Hospitals Plymouth NHS Trust, who have become the first centre in the UK to...Read More
+

BSIR 2025 11th – 13th November 2025

We are excited to be supporting this year’s BSIR Annual Scientific Meeting at the ACC Liverpool....Read More

Upcoming events

5th – 6th February 2026: The 28th BSGAR Annual Meeting
17th March 2026: UK Biliary Intervention Study Day
23rd – 24th March 2026: Vascular Innovations and Technological Advancements Learning Symposium
7th May 2026: Liver Intervention Study Day

For more information, email Aquilant.newsletter@hc21.group or visit healthcare21.eu